NCT01195363View on ClinicalTrials.gov

Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

June 30, 2011

Conditions
Bipolar Disorder
Interventions
DRUG

quetiapine SR

quetiapine SR, dose range 200-600mg, each night QHS for 6mos

DRUG

quetiapine sr placebo

quetiapine sr placebo, dose range 200-600mg, each night QHS for 6mos

Trial Locations (1)

78229

The University of Texas Health Science Center at San Antonio, San Antonio

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER